The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

Among the significant measures introduced by the Act, including action on clean energy and climate change, the IRA introduces – for the first time – provisions to reduce federal spending on medicines.

Today marks Rare Disease Day 2025. This time last year we published an Article entitled “ Why do we care about rare? ”, summarising the origins of rare disease day, the fundamental ambition – to ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

We conducted a quantitative preference study to understand how well the criteria of NICE’s severity modifier align with UK societal preferences. Our primary objectives were to estimate: Cut-offs for ...

While global HIV incidence has declined by 39% since 2010, many member states of the World Health Organisation (WHO) are witnessing a rise in new diagnoses, with certain regions in Europe ...

This panel brings together leading researchers to explore how health economics can inform policy design in the context of the climate crisis. Rather than proposing new evaluative paradigms, the ...

Drug shortages are an industry-wide problem. Numerous factors may be considered as contributing to drug shortages across the globe. In this report, we discuss the global issue of drug shortages, ...